Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Interim analysis of phase II clinical trials on XL-999

June 11, 2007

Data presented at ASCO for AEZS-108, a targeted cytotoxic-LHRH conjugate

June 11, 2007

Encouraging phase I results obtained for sapacitabine in hematological cancers

June 11, 2007

Novel Ras inhibitor has promising activity and safety in hematological malignancies

June 11, 2007

Genomic Health reports new data for Oncotype DX breast cancer assay

June 11, 2007

Abbott and Caprion extend discovery partnership in oncology

June 11, 2007

Japanese priority review for Taxotere in hormone refractory prostate cancer

June 8, 2007

Ongoing phase I clinical trials evaluating different dose schedules of E-7974

June 8, 2007

Antisense p53 production inhibitor improves efficacy and tolerability of cytarabine/idarubicin

June 8, 2007

Targeted chemotherapeutic EC-145 advances to phase II clinical trials

June 8, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026